AKT1 and small intestine neoplasm: KYA1797K treatment decreased the levels of β-catenin and Ras proteins as well as the activities of Erk and Akt in the small intestinal tumors of the ApcMin/+/K-rasG12DLA2 mice reducing both of their number and size of tumors (Fig. 3a-c).